Silicon Valley has a long history with psychedelics, and some of its best-known leaders have partaken, including Steve Jobs ...

WHILE KETAMINE OFTEN comes up in conversations about psychedelic medicine, technically it’s part of a class of drugs called ...

In this podcast, host Mary Long caught up with Motley Fool contributor Keith Speights to check in on the psychedelics ...

Kennedy Jr. took to the social media site X (formerly Twitter) last month to threaten the Food and Drug Administration, he ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

The conversation around psychedelics has shifted dramatically in recent years. Once stigmatized as counterculture drugs, psychedelics like psilocybin (found in ...

A clinical trial found psilocybin treatment for anorexia nervosa led to profound psychological shifts and reduced eating ...

A bipartisan panel of Georgia lawmakers on Wednesday endorsed a plan recommending the state spend up to $5 million studying ...

Groundbreaking research reveals that it's possible to isolate the therapeutic benefits of psychedelics from their ...

COMPASS Pathways faces $43M market cap loss, raising concerns among institutional investors holding 30% ownership.

Set to hit shelves on Handler’s actual birthday, Feb. 25, 2025, the memoir in essays is a highlight reel of sorts, telling ...